Aarti Drugs Limited
NSE:AARTIDRUGS.NS
Overview | Financials
Company Name | Aarti Drugs Limited |
Symbol | AARTIDRUGS.NS |
Currency | INR |
Price | 490 |
Market Cap | 44,722,300,000 |
Dividend Yield | 0.21% |
52-week-range | 431.05 - 635 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Prakash Moreshwar Patil |
Website | https://www.aartidrugs.co.in |
An error occurred while fetching data.
About Aarti Drugs Limited
Aarti Drugs Limited, through its subsidiaries, engages in the pharmaceuticals business in India and internationally. The company offers active pharmaceutical ingredients in various therapeutic categories, including anti-inflammatory, cardioprotectants, antidiarrhoeals, antifungals, antiarthritis/osteoporosis, antibiotics, antidiabetics, Alzheimer's treatment, sedatives, vitamins, and alcoholism treatment; and pharmaceutical intermediate products comprising tinidazole, celecoxib, ciprofloxacin, clopidogrel, diclofenac,
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD